BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6210684)

  • 1. Kinetics of mezlocillin in patients with biliary t-tube drainage.
    Gundert-Remy U; Förster D; Schacht P; Weber E
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():65-75. PubMed ID: 6210684
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative biliary excretion of mezlocillin and 12 other beta-lactam antibiotics (author's transl)].
    Comte F; Brogard JM; Kopferschmitt J; Dorner M; Lavillaureix J
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):353-60. PubMed ID: 6460975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biliary excretion and pharmacokinetics of mezlocillin in jaundiced patients with external bile drainage.
    Dooley JS; Gooding A; Hamilton-Miller JM; Brumfitt W; Sherlock S
    Liver; 1983 Aug; 3(4):201-6. PubMed ID: 6672502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biliary excretion of mezlocillin].
    Rösch W; Stock KP; Burkhardt F
    Fortschr Med; 1981 Jan; 99(3):76-8. PubMed ID: 6451569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary elimination of mezlocillin: an experimental and clinical study.
    Brogard JM; Kopferschmitt J; Arnaud JP; Dorner M; La Villaureix J
    Antimicrob Agents Chemother; 1980 Jul; 18(1):69-76. PubMed ID: 6448023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental and clinical study of the biliary elimination of mezlocillin (author's transl)].
    Brogard JM; Kopferschmitt J; Dorner M; Lavillaureix J
    Pathol Biol (Paris); 1981 Sep; 29(7):405-10. PubMed ID: 6457274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bile composition and antibiotic excretion. Observations with T-drainage].
    Rosenthal RJ; Steigerwald SD; Bockhorn H
    Z Gesamte Inn Med; 1993 Jan; 48(1):18-22. PubMed ID: 8095119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of mezlocillin in each specialty. Round table].
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):386-92. PubMed ID: 6460982
    [No Abstract]   [Full Text] [Related]  

  • 9. Biliary excretion of mezlocillin in patients with hepatic disease.
    Hildebrandt R; Gundert-Remy U; Raedsch R; Sieg A; Stiehl A
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent pharmacokinetics of mezlocillin in subjects with normal and impaired renal function.
    Mangione A; Janicke DM; Boudinot FD; Schultz RM; Jusko WJ
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():81-5. PubMed ID: 6210686
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimation of biliary excretion of ureidopenicillins in healthy volunteers using marker dilution technique.
    Gundert-Remy U; Frohnapfel F; Jourdan W; Weber E; Stiehl A
    Br J Clin Pharmacol; 1982 Jun; 13(6):795-801. PubMed ID: 6212074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies on the biliary excretion of mezlocillin, especially in cases with liver dysfunction].
    Maeba T; Hashimoto T; Takeda T; Shiraishi Y; Oike H; Wakabayashi H; Omori G; Indo S; Kunikata E; Hayashi M
    Jpn J Antibiot; 1986 Jan; 39(1):116-20. PubMed ID: 3702053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies of mezlocillin in newborn infants.
    Rubio T; Wirth F; Karotkin E
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():241-4. PubMed ID: 6210673
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of biliary tract infections (XXIV). Biliary excretion and gallbladder tissue levels of mezlocillin].
    Kobayashi N; Tanimura H; Huang WF; Sekiya T; Takahashi H; Sato T; Yoshida K; Hikasa Y
    Jpn J Antibiot; 1984 Apr; 37(4):597-604. PubMed ID: 6471380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Should antibiotic prevention be used in biliary tract surgery?].
    Gruber UF; Elke R; Widmer M; Trippel M; Gerber H
    Schweiz Med Wochenschr; 1983 Apr; 113(15):558-9. PubMed ID: 6222473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary excretion of aztreonam in patients with biliary tract disease.
    Martinez OV; Levi JU; Devlin RG
    Antimicrob Agents Chemother; 1984 Mar; 25(3):358-61. PubMed ID: 6539092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mezlocillin elimination in patients with impaired renal function.
    Aronoff GR
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():77-9. PubMed ID: 6210685
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonlinear mezlocillin kinetics due to dose-dependent metabolism.
    Gundert-Remy U; Hildebrandt R; Stiehl A; Weber E
    Clin Pharmacol Ther; 1983 May; 33(5):656-62. PubMed ID: 6220858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial elimination and antibiotic concentration in the gall-bladder during biliary tract infections treated with mezlocillin (author's transl)].
    Helm EB; Wurbs D; Gundlach H; Beyer B; Hagenmüller F; Stille W
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1087-90. PubMed ID: 6455282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of azlocillin in patients with biliary t-tube drainage.
    Gundert-Remy U; Weber E
    Eur J Clin Pharmacol; 1982; 22(5):435-9. PubMed ID: 7117356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.